These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16234344)

  • 21. Digital screening methodology for the directed evolution of transglycosidases.
    Koné FM; Le Béchec M; Sine JP; Dion M; Tellier C
    Protein Eng Des Sel; 2009 Jan; 22(1):37-44. PubMed ID: 18996967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of cluster structure-activity relationship analysis in efficient high-throughput screening.
    Wang XS; Salloum GA; Chipman HA; Welch WJ; Young SS
    J Chem Inf Model; 2007; 47(3):1206-14. PubMed ID: 17480051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combinatorial engineering to enhance amylosucrase performance: construction, selection, and screening of variant libraries for increased activity.
    van der Veen BA; Potocki-Véronèse G; Albenne C; Joucla G; Monsan P; Remaud-Simeon M
    FEBS Lett; 2004 Feb; 560(1-3):91-7. PubMed ID: 14988004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the design and analysis of high-throughput screening technology comparison experiments using statistical modeling.
    Woodward PW; Williams C; Sewing A; Benson N
    J Biomol Screen; 2006 Feb; 11(1):5-12. PubMed ID: 16234338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative digital image analysis of chromogenic assays for high throughput screening of alpha-amylase mutant libraries.
    Shankar M; Priyadharshini R; Gunasekaran P
    Biotechnol Lett; 2009 Aug; 31(8):1197-201. PubMed ID: 19360387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel screening assay for hydroxynitrile lyases suitable for high-throughput screening.
    Krammer B; Rumbold K; Tschemmernegg M; Pöchlauer P; Schwab H
    J Biotechnol; 2007 Mar; 129(1):151-61. PubMed ID: 17157404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design.
    Chica RA; Doucet N; Pelletier JN
    Curr Opin Biotechnol; 2005 Aug; 16(4):378-84. PubMed ID: 15994074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micro-colony array based high throughput platform for enzyme library screening.
    Pohn B; Gerlach J; Scheideler M; Katz H; Uray M; Bischof H; Klimant I; Schwab H
    J Biotechnol; 2007 Mar; 129(1):162-70. PubMed ID: 17174002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
    Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
    J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The quest for molecular quasi-species in ligand-activity space and its application to directed enzyme evolution.
    Mannervik B; Runarsdottir A
    FEBS Lett; 2010 Jun; 584(12):2565-71. PubMed ID: 20399208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase.
    Brandish PE; Chiu CS; Schneeweis J; Brandon NJ; Leech CL; Kornienko O; Scolnick EM; Strulovici B; Zheng W
    J Biomol Screen; 2006 Aug; 11(5):481-7. PubMed ID: 16760370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple strategy for mitigating the effect of data variability on the identification of active chemotypes from high-throughput screening data.
    Johnson SR; Padmanabha R; Vaccaro W; Hermsmeier M; Cacace A; Lawrence M; Dickey J; Esposito K; Pike K; Wong V; Poss M; Loughney D; Tebben A
    J Biomol Screen; 2007 Mar; 12(2):276-84. PubMed ID: 17272827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Directed evolution of a thermophilic beta-glucosidase for cellulosic bioethanol production.
    Hardiman E; Gibbs M; Reeves R; Bergquist P
    Appl Biochem Biotechnol; 2010 May; 161(1-8):301-12. PubMed ID: 19834652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the InteraX system technology in a high-throughput screening environment.
    Büttner FH; Kumpf R; Menzel S; Reulle D; Valler MJ
    J Biomol Screen; 2005 Aug; 10(5):485-94. PubMed ID: 16093558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating cell-level kinetic modeling into the design of engineered protein therapeutics.
    Rao BM; Lauffenburger DA; Wittrup KD
    Nat Biotechnol; 2005 Feb; 23(2):191-4. PubMed ID: 15696150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling the separation of macromolecules: a review of current computer simulation methods.
    Slater GW; Holm C; Chubynsky MV; de Haan HW; Dubé A; Grass K; Hickey OA; Kingsburry C; Sean D; Shendruk TN; Zhan L
    Electrophoresis; 2009 Mar; 30(5):792-818. PubMed ID: 19260004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Framework for the rapid optimization of soluble protein expression in Escherichia coli combining microscale experiments and statistical experimental design.
    Islam RS; Tisi D; Levy MS; Lye GJ
    Biotechnol Prog; 2007; 23(4):785-93. PubMed ID: 17592858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PeneloPET, a Monte Carlo PET simulation tool based on PENELOPE: features and validation.
    España S; Herraiz JL; Vicente E; Vaquero JJ; Desco M; Udias JM
    Phys Med Biol; 2009 Mar; 54(6):1723-42. PubMed ID: 19242053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Mutational SURF': a strategy for improving lead compounds identified from combinatorial libraries.
    Freier SM; Konings DA; Wyatt JR; Ecker DJ
    Bioorg Med Chem; 1996 May; 4(5):717-25. PubMed ID: 8804538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.